Inactive Instrument

REBEL CAP 2.

Equities

RBZ.P

CA75617D1087

Rebel Capital 2.0 Corp. Terminates Its Business Combination Agreement with Alzex Biomedical Group Inc. Effective Immediately

September 25, 2020 at 03:39 pm EDT

Rebel Capital 2.0 Corp. announced that it has terminated its business combination agreement with Alzex Biomedical Group Inc. effective immediately. The Company is exploring new business opportunities with a view to undertaking a transaction which would constitute Rebel's ‘Qualifying Transaction’.

Latest news about REBEL CAP 2.

Wedge Lake Property in Saskatchewan acquired Rebel Capital 2.0 Corp. for in a reverse merger transaction.	22-12-15	CI
Rebel Capital 2.0 Corp. announced that it has received CAD 0.76 million in funding	22-12-15	CI
Rebel Capital 2.0 Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-28	CI
Rebel Capital 2.0 Corp. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-26	CI
Rebel Capital 2.0 Corp. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-30	CI
Rebel Capital 2.0 Corp. Reports Earnings Results for the Full Year Ended December 31, 2021	22-02-10	CI
Rebel Capital 2.0 Corp. Auditor Raises 'Going Concern' Doubt	22-02-09	CI
Rebel Capital 2.0 Corp. Enters into Definitive Agreement, Pursuant to Which It Will Acquire the Mineral Property Option to the Wedge Lake Property in Saskatchewan, Canada	21-11-03	CI
Rebel Capital 2.0 Corp. announced that it expects to receive CAD 0.6 million in funding	21-11-02	CI
Rebel Capital 2.0 Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-10-18	CI
Rebel Capital 2.0 Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-07-12	CI
Rebel Capital 2.0 Corp. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-14	CI
Rebel Capital 2.0 Corp. Reports Earnings Results for the Full Year Ended December 31, 2020	21-02-11	CI
Rebel Capital 2.0 Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-10-16	CI
Rebel Capital 2.0 Corp. Terminates Its Business Combination Agreement with Alzex Biomedical Group Inc. Effective Immediately	20-09-25	CI
Alzex Biomedical Group Inc. cancelled the acquisition of Rebel Capital 2.0 Corp. (TSXV:RBZ.P) in a reverse merger transaction.	20-09-24	CI
Rebel Capital 2.0 Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2020	20-07-21	CI
Rebel Capital 2.0 Corp. Reports Earnings Results for the First Quarter Ended March 31, 2020	20-05-13	CI
Rebel Capital 2.0 Corp. Reports Earnings Results for the Full Year Ended December 31, 2019	20-04-24	CI
Rebel Capital 2.0 Corp. announced that it expects to receive CAD 5 million in funding	19-11-26	CI
Rebel Capital 2.0 Corp. Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-12	CI
Alzex Biomedical Group Inc. entered into a letter of intent to acquire Rebel Capital 2.0 Corp. (TSXV:RBZ.P) in a reverse merger transaction.	19-09-30	CI
Rebel Capital 2.0 Corp. Announces Management Changes	19-09-23	CI
Rebel Capital Intends To Seek Acquisitions	19-08-27	CI
Rebel Capital 2.0 Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-19	CI

Chart REBEL CAP 2.

Duration

Period

More charts

Company Profile

Rebel Capital 2.0 Corp. is a Canada-based capital pool company. The principal business of the Company is identification and evaluation of assets or businesses with a view to potentially acquire them or an interest therein. The purpose of such an acquisition is to satisfy the related conditions of a qualifying transaction.

Sector

More about the company